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ABSTRACT. Polyethyleneimine-coated double-walled carbon nanotubes (DWCNTs) were used for 
dual gene and drug delivery, after loading the DWCNTs with the drug chloroquine, a lysosomotropic 
compound that is able to promote escape from the lysosomal compartment. Different forms of 
functionalization of the DWCNTs were examined in order to optimize this system. They included the 
testing of different treatments on DWCNTs to optimize the loading and delivery of chloroquine and the 
selection of a cationic polymer for coating the DWCNTs for optimum DNA binding and delivery. An 
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acid oxidation treatment of DWCNTs was selected for optimum chloroquine loading together with 
polyethyleneimine as optimum cationic coating agent for plasmid DNA binding. Optimization of the 
conditions for choroquine-enhanced gene delivery were developed using luciferase expression as a 
model system. We have demonstrated that chloroquine-loading increases the ability of 
polyethyleneimine-coated DWCNTs to deliver functional nucleic acid to human cells. Cell viability 
tests have shown no cytotoxicity of the functionalized DWCNTs at the concentrations needed for 
optimum gene delivery. These results support the potential applications of this methodology in gene 
therapy. 
1. Introduction 
Carbon nanotubes (CNTs) emerged as a new tool in nanobiotechnology and nanomedicine, 
particularly since new functionalization methods were carried out to enhance their biocompatibility and 
develop novel medical therapeutics [1,2]. One of the most promising applications of CNTs in the 
biomedical field is in gene therapy. CNTs have been shown to be efficiently internalized by mammalian 
cells [3] and able to deliver gene cargoes [4]. However, transfection efficiencies obtained in cells and 
small animal models are not yet comparable to those reached with other delivery systems, such as viral 
vectors [5]. It is likely that the relatively low efficiencies are due to inefficient penetration of barriers at 
systemic tissue and cellular levels that the vector has to be able to overcome in order to reach its target 
and deliver its cargo [6]. A key barrier to overcome in order to obtain efficient gene expression is 
intracellular trafficking of the internalized vector [7]. Nucleic acid degradation during passage through 
the cellular internalization pathways is likely to play a key role in the ability of any vector to deliver a 
functional nucleic acid to its target in the nucleus (for DNA) or to the gene expression machinery (for 
RNA) in the cytoplasm. However, most non-viral vectors, including CNTs, have shown to be 
internalized by endocytosis [8] which leads to entrapment and degradation of the genetic material in 
lysosomes. Escape of delivered cargo from the lysosomal degradative pathway is likely to be crucial to 
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development of therapeutic application of CNT delivery [9].  Several strategies have been developed to 
overcome the intracellular DNA degradative barrier for other nucleic acid delivery systems based on the 
destabilization of endosomal and lysosomal membranes [10]. For example, addition of lysosomotropic 
compounds in the cultured media has been reported to greatly enhance the transfection efficiency [11]. 
These compounds are weak bases that become protonated at the acidic pH inside the lysosomes and, in 
consequence, cause a swelling and rupture of the endocytic vesicle, releasing delivered genetic material 
into the cytoplasm. Carbon nanotubes can be exohedrically functionalized by attaching different 
functional groups or cargoes to the external walls [12,13], but can also be filled with different 
compounds [14,15], although optimization of filling and release remains problematic [16]. In this 
context, double-walled carbon nanotubes (DWCNTs) are a versatile material for a carrier design as the 
outside can be functionalized without modifying the integrity of the inner tube, leaving it intact for 
filling. The toxicity of the DWCNTs used in this work has been investigated extensively in earlier work 
[3,17,18], as well as their potential environmental impact [19,20]. Theoretical studies have investigated 
the filling and loading on the external walls of CNTs with different anticancer drugs [13,21] and 
subsequent release for therapeutic purposes [22]. However, the loading of CNTs with a compound to be 
co-delivered with plasmid DNA to improve gene delivery has not so far been investigated. We report 
for the first time the loading of DWCNTs with the lysosomotropic anti-malarial drug chloroquine and 
demonstrate its ability to enhance the cell transfection efficiency. 
2. Experimental 
2.1 Materials 
Chloroquine diphosphate salt, poly(Lys:Phe) 1:1 hydrobromide (PLP), polyethylenimine (PEI), RNA 
from baker’s yeast were purchased from Sigma. DSPE-PEG(2000)-amine (DSPEA-PEG) was 
purchased from Avanti Polar Lipids. pGL3-control vector and Bright-GloTM luciferase assay system 
were purchased from Promega. Qiaprep Spin MiniPrep Kit was purchased from Qiagen. DC Protein 
Assay was purchased from Bio-Rad. Opti-MEM I Reduced-Serum Medium (1x) and MEM medium 
were purchased from Invitrogen. 
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2.2 Synthesis of DWCNTs 
DWCNTs were produced by CCVD decomposition of CH4 over Mg(1-x)CoxO solid solution, 
containing small addition of molybdenum, as described earlier [23]. After the CCVD synthesis, the 
remaining oxide material, as well as the unprotected metal (Co, Mo) particles, were removed by 
treatment of the sample with concentrated aqueous HCl solution. The acidic suspension was filtered on 
0.45 µm pore size cellulose nitrate membrane (Whatman) and washed with deionized water until 
neutrality. The resulting DWCNTs, denoted extracted DWCNTs (raw DWCNTs), were then dried 
overnight in an oven, at 80 °C [24]. High-resolution transmission electron microscopy showed that a 
typical sample consists of ca. 80 % DWCNTs, the rest being SWCNTs (ca. 15%) and a few triple-
walled carbon nanotubes (ca. 5%). The diameter distribution of the DWCNTs ranged from 0.5 to 2.5 nm 
for inner tubes and from 1.2 to 3.2 nm for outer tubes. The length of individual DWCNTs usually ranges 
between 1 and 10 micrometers, although bundles may be much longer (up to 100 micrometers at least) 
[23].  
Two different treatments of the raw DWCNTs were performed a) an oxidation treatment and, b) an 
opening treatment. These treatments were used to optimize the chloroquine loading on DWCNTs and 
therefore, the loading yield was compared for raw, oxidized and opened DWCNTs. a) Oxidation 
treatment: the walls of the DWCNTs were not expected to be functionalized during the synthesis and 
catalyst-elimination conditions [25]; so an additional post-synthesis treatment was required, in order to 
obtain oxygen-containing functional groups on the outer wall of the raw DWCNTs. This was achieved 
with nitric acid treatment which produces mainly carboxylic groups [26]. A sample of oxidized 
DWCNT was thus prepared by refluxing raw DWCNTs (30 mg) in nitric acid solution (30 mL, 3 M), at 
130 °C. After 24 h, the obtained suspension was filtered and the DWCNTs were washed with deionized 
water until a neutral pH was obtained. A ten-minute tip-sonication step in deionized water was used to 
disperse the oxidized DWCNTs. After re-filtration, the so-called oxidized DWCNTs were dried 
overnight in an oven at 80 °C. b) Opening treatment: raw DWCNTs were also opened by treatment with 
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solid NaOH [27]. Briefly, raw DWCNTs (30 mg) were intimately mixed in glove-box conditions with 
NaOH (ca. 122.3 mg), with a purity of 98.5+ % (Aldrich), in an approximate molar ratio of 1 : 1.3 [28]. 
The grey mixture-powder was then transferred into a quartz ampoule and sealed under vacuum. It was 
finally placed in a tubular furnace and heated at 3 °C min-1 to 418 °C (100 °C above the melting point of 
NaOH, 318 °C). The sample was kept for 240 min at this temperature and it was then slowly cooled 
down to room temperature at 1 °C min-1. A black agglomerate with metallic reflects was obtained, 
which was again ground in a mortar, until a powder was obtained. In order to eliminate the excess of 
NaOH (at the surface of the tubes), the resulting powder was then transferred into a small quantity of 
deionized water, sonicated for 1 min in a sonication bath, filtered and then washed with deionized water. 
A reflux step, under continuous stirring in deionized water at 80 °C was used to eliminate the remaining 
excess of NaOH. After 24 h, the obtained grey suspension was filtered and the DWCNTs were washed 
with deionized water, until the colour of the filtrate could no longer be observed. The so-called opened 
DWCNTs were obtained from the filtration-membrane and dried overnight in an oven, at 80 °C.  
2.3 Chloroquine loading of DWCNTs  
About 15 mg of each non-loaded raw, oxidized and opened DWCNTs were loaded in solution with an 
excess of chloroquine diphosphate salt [29,30]. This anti-malarial drug is very soluble in water (100 mg 
mL-1) and extremely sensitive to sunlight. For the loading of each type of DWCNTs, we followed the 
same procedure. In a first step, three identical solutions were prepared: chloroquine diphosphate salt 
(4750 mg) was quickly dissolved in deionized water (50 mL) (30 s of bath sonication). Then, DWCNTs 
(15 mg of raw or oxidized or opened) were added to the corresponding solution and stirred 24 h at room 
temperature. The flasks were all the time protected from sunlight with aluminium foil. Free chloroquine 
was removed by filtration and subsequent washing steps. After 24 h, the three solutions were filtered to 
obtain chloroquine-loaded raw, oxidized and opened DWCNTs. The tubes were washed with few drops 
of deionized water and then ethanol, followed by drying under vacuum at room temperature. 
2.4 Coating of DWCNTs with cationic polymers  
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Raw DWCNTs, oxidized DWCNTs (with HNO3, 3M) and opened DWCNTs (with NaOH) were 
coated with different cationic polymers: polyethyleneimine (PEI), poly(Lys:Phe, 1:1) (PLP) and 1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol) 2000 (DSPE-PEG-NH2). 
Each kind of non-coated DWCNTs (1 mg) was respectively mixed with the cationic polymer solution in 
deionized water (1 mL of 2 mg mL-1 for PEI and 1 mL of 0.5 mg mL-1 of PLP and DSPE-PEG-NH2). 
The mixtures were sonicated in a tip sonicator (Soniprep 100 W of output power, set at 20 % of 
maximum amplitude) for 100 s in 10 cycles of 10 s on 10 s off. The suspensions were centrifuged at 
5000 rpm for 3 min and the supernatant was filtered in ultrafiltration tubes of 0.1 µm from Millipore. 
The filtrates were washed 4 times with deionized water (50 µL), resuspended in deionized water (0.5 
mL) and ultrasonicated for 20 s (2 cycles of 10 s on 10 s off). 
2.5 Coating of DWCNTs with RNA  
Raw DWCNTs, oxidized DWCNTs and opened DWCNTs were treated with RNA. Each kind of 
DWCNTs (2 mg) were mixed with RNA solution in deionized water (1 mL of 4 mg mL-1) and 
ultrasonicated (Soniprep 100 W of output power, set at 20 % of maximum amplitude) for 100 s in 10 
cycles of 10 s on 10 s off. Then, deionized water (1 mL) was added and the mixtures were sonicated in a 
100 W water bath for 1 h. The suspensions were filtered on ultrafiltration tubes of 0.1 µm from 
Millipore. Each filtrate was washed 3 times with deionized water (50 µL) and resuspended in deionized 
water (1 mL).  
2.6 Agarose gel electrophoresis for quantification of the chloroquine-loading of DWCNTs 
0.8 % agarose gel electrophoresis in TAE buffer (mixture of tris base 40 mM, acetic acid 40 mM and 
EDTA 1 mM) was used to characterize the chloroquine loading of the DWCNTs and the release of the 
drug from the carbon nanotubes. Gel electrophoresis was run for 30 min at 90 V with 40 % sucrose 
solution in deionised water as loading buffer (the final concentration of sucrose in the loaded samples 
was 6.7 %). Chloroquine on its own was loaded in the gel as control to a concentration in the range of 
(5-75) µM. Chloroquine-loaded raw, oxidized and opened DWCNTs were also coated with RNA prior 
to electrophoresis. For this step, each kind of chloroquine-loaded DWCNTs (2 mg) were mixed with 
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RNA solution (1 mL of 4 mg mL-1) and ultrasonicated for 100 s (Soniprep 100 W of output power, set 
at 20 % of maximum amplitude, 10 cycles of 10 on and 10 s off). RNA-coated carbon nanotubes were 
well dispersed and no centrifugation was carried out so that the amount of carbon nanotubes loaded onto 
the gel was accurately known. The suspensions were filtered on 0.1 µm hydrophilic PVDF filtration 
membranes and the solid was washed with deionized water. Each solid was resuspended in deionized 
water (1 mL). For the quantification of the chloroquine-loading, each sample of RNA-coated DWCNTs 
(20 µL of 0.24 mg mL-1) dispersed in deionized water and in 0.3 % hydrochloric acid were mixed with 
the loading buffer (4 µL) and loaded into each well.  
2.7 Kinetics of chloroquine release from DWCNTs  
Gel electrophoresis, as described above, was run for 30 min at 90 V with 40 % sucrose as loading 
buffer. Filled DWCNTs were functionalized by wrapping with the amphiphilic polypeptide 
poly(Lys:Phe, 1:1). Each kind of chloroquine-loaded DWCNTs (1 mg) was respectively mixed with 
poly(Lys:Phe, 1:1) (1 mL of 2 mg mL-1). The mixtures were ultrasonicated for 100 s (Soniprep 100 W 
of output power, set at 20 % of maximum amplitude, 10 cycles of 10 s on, 10 s off) and centrifuged at 
100 rpm for 5 min. The supernatants were filtered and washed with deionized water on 0.1 µm filtration 
membranes. Each solid was resuspended in deionized water (0.75 mL). The poly(Lys:Phe, 1:1)-coated 
chloroquine-loaded DWCNTs (300 µL of 60 µg mL-1 ) were mixed with universal buffer 0.1 M pH 4.8 
or 7.4 (50 µL). Universal buffer was prepared from an equimolar mixture of phosphoric acid, boric acid 
and acetic acid and adjusting the pH with NaOH 1M or HCl 1M. The mixtures of poly(Lys:Phe, 1:1)-
coated chloroquine-loaded DWCNTs were incubated in a water bath at 37 oC for 24 h. Aliquots (50 µL) 
were removed after universal buffer addition (t = 0), and after 30 min, 60 min, 90 min, 2 h, 3 h, 24 h. 
The aliquots were filtered on 0.1 µm filtration membranes and the filtrate kept at -4 oC before 
electrophoresis. The gel was run for 30 min at 90 V. 
2.8 Delivery of luciferase gene into HeLa cells  
For the preparation of the transfection mixtures, the appropriate amount of PEI-coated DWCNTs 
(loaded or non-loaded with chloroquine) was mixed with the solution of pGL3 plasmid and incubated 
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for 30 min prior transfection. These DWCNTs-PEI-pGL3 complex solutions (250 µL) were mixed with 
Opti-MEM Reduced Serum Media (Invitrogen) (250 µL) and supplemented with 1 % antibiotics 
(penicillin/streptomycin). HeLa cells were cultured in 24-well plates in D-MEM (Invitrogen) without 
antibiotics until they reached 75 % confluence. The cells were then washed with PBS and incubated 
with the transfection mixtures as described above for 4 h at 37 °C. After 4 h, 1 mL of MEM 
supplemented with 10 % Fetal Bovine Serum, 1 % non essential amino acids and 1 % antibiotics 
(penicillin/streptomycin) was added without removing the transfection mixture and the cells were 
incubated overnight in this medium. The medium was then replaced by fresh media and the cells were 
incubated for 48 h to express the luciferase gene.  
2.9 Luciferase assay  
Cells were washed twice with PBS and incubated for 15 min with lysis buffer (100 µL). After 
scraping the cells off the dish, the lysate was centrifuged for 15 s at 12000xg at room temperature and 
the supernatant was transferred into a new tube and kept on ice to perform the luciferase assay. 
Luciferase substrates (Bright-Glo™ Luciferase Assay System from Promega) (50 µL) was mixed with 
the lysate (50 µL) and luminescence signal was recorded in a well plate reader and averaged over 5 
minutes. Total protein was determined in the cell lysate by the Bio-Rad DC Protein Assay which is a 
colorimetric method based on the Lowry assay [31].  
2.10 MTT cell viability assay  
Cells were seeded in a 96-well plate at 5000-10000 cells per well in 200 µL of media and incubated 
overnight. 100 µL of media +/- RNA-coated oxidized or open non-loaded and loaded DWCNTs was 
added to each well and cells incubated for three days. MTT was added to each well (10 µL) and 
incubated at 37 oC for three hours. The media was removed and 200 µL of DMSO was added per well to 
disolve the formazan crystals. Finally, the absorbance values at 570 nm (working wavelength) and 630 
nm (reference wavelength) were used as a measurement of cell viability. 
2.11 Characterization of DWCNTs  
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Raman spectroscopy: Raman spectra of the non-loaded DWCNTs were obtained at 633 nm, with a 
LabRAM HR 800 (Jobin and Yvon) spectrometer. Chemical analysis: Elemental analysis was 
performed by Atomic Emission Spectroscopy (AES). HR-TEM: The HR-TEM was carried out using a 
High Resolution Transmission Electron Microscope JEOL-JEM-2100F (operated at 200 kV). For 
sample preparation, chloroquine-loaded DWCNTs were briefly dispersed in ethanol. A few drops of 
each suspension were then deposited onto a 300 mesh Lacey copper TEM grid placed on absorbing 
paper. 
3. Results and discussion 
3.1 Synthesis and characterization of the chloroquine-loaded DWCNTs. 
The purpose of this work is to synthesize a gene delivery vector able to carry and co-deliver a 
lysosomotropic drug in order to enhance the transfection efficiency. For this purpose, DWCNTs were 
selected because of their versatility, as both their external wall and inner tube can be functionalized for 
loading with different compounds, and because of their no toxicity at concentrations potentially useful 
for biomedical applications. Compared to common sources, they present the advantage of being 
perfectly characterized in terms of morphology and purity, as well as toxicity thanks to earlier studies 
[3,17,18,19,20]. They also offer a better chemical and mechanical stability as compared to single-walled 
carbon nanotubes (SWCNTs) and thus represent the optimal choice in terms of drug/container weight 
ratio. DWCNTs were coated with a cationic polymer in order to bind plasmid DNA through ionic 
interactions, and loaded with a lysosomotropic drug to obtain an efficient gene delivery vector. The 
selected lysosomotropic drug was chloroquine, that promotes a lysosomal escape of the delivery vector 
avoiding the DNA degradation in the cellular compartment. In this section, DWCNTs were tested first 
for their ability to be loaded with chloroquine. Raw DWCNTs were synthesized as previously described 
[23] and were subjected to two different types of treatments: a) an oxidation treatment with 3 M nitric 
acid which generates carboxylic acid groups on the CNT walls but also opens the tubes and, b) a 
treatment with NaOH which opens the tubes but does not functionalize them. The three types of 
DWCNTs (raw, oxidized and opened) were compared in their ability to be loaded with chloroquine in 
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order to select the optimum starting DWCNT material for drug loading and subsequent release. For 
simplicity, the different types and combinations of functionalized DWCNTs that will be used 
throughout the manuscript are described in table 1. According to this table, the three types of DWCNTs 
that will be compared for chloroquine loading are the ones denoted as ((1), (2) and (3)).   
 
Construct 
number 
Chloroquine 
loading procedure 
Chloroquine 
loading 
DWCNT 
coating 
pGL3 plasmid 
loading 
(1) raw DWCNT No No No 
(2) oxidized DWCNT No No No 
(3) opened DWCNT No No No 
(4) raw DWCNT Yes No No 
(5) oxidized DWCNT Yes No No 
(6) opened DWCNT Yes No No 
(7) raw DWCNT No RNA No 
(8) oxidized DWCNT No RNA No 
(9) opened DWCNT No RNA No 
(10) raw DWCNT Yes RNA No 
(11) oxidized DWCNT Yes RNA No 
(12) opened DWCNT Yes RNA No 
(13) oxidized DWCNT Yes PLP No 
(14) opened DWCNT Yes PLP No 
(15) oxidized DWCNT No DSPEA-PEG Yes 
(16) oxidized DWCNT Yes DSPEA-PEG Yes 
(17) oxidized DWCNT No PLP Yes 
(18) oxidized DWCNT Yes PLP Yes 
(19) oxidized DWCNT No PEI Yes 
(20) oxidized DWCNT Yes PEI Yes 
(21) opened DWCNT No PEI Yes 
(22) opened DWCNT Yes PEI Yes 
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(23) raw DWCNT No PEI Yes 
(24) raw DWCNT Yes PEI Yes 
 
Table 1. Different types of DWCNTs used in this work. 
 
As prepared (1)-(3) DWCNTs were first characterized by Raman Spectroscopy. As it can be seen in 
Figure 1, differences in the Raman D and G bands, which are an indicator of the level of defects of the 
sample [31], are observed. In this way, an increasing ID/IG intensity ratio corresponds to a higher level 
of defects and a decreasing ID/IG ratio corresponds to a higher level of structural quality. The oxidation 
treatment or raw DWCNT produces an increase in the ID/IG ratio (ID/IG ratio increases from 0.18 for 
(1) to 0.44 for (2)). Oxidation with nitric acid is known to remove impurities from CNTs (such as 
amorphous carbon and metals), and therefore this increase in ID/IG ratio is indicating an increase in the 
defects in the carbon material which is also consistent with previous studies that have demonstrated that 
this treatment increases defects in carbon compounds [32]. Besides, NaOH treatment of raw DWCNTs 
produces a decrease in the ID/IG ratio from 0.18 for (1) to 0.10 for (3). This is consistent with previous 
studies that have demonstrated that treatment with molten NaOH is a recognized single step process for 
the simultaneous purification and opening of raw carbon nanotubes [33]. 
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Figure 1. Raman spectra of the non-loaded DWCNTs. Comparison between raw (__) and oxidized (- -) 
DWCNTs. 
Chloroquine diphosphate salt (C18H26ClN3˙2H3PO4) was used for the loading of DWCNTs samples 
(1)-(3). Chloroquine is a hydrophobic weak base with a quinoline aromatic ring that can interact with 
CNT walls, both the external and the inner walls, through hydrophobic interactions (pi-pi stacking 
interactions). The DWCNTs used for this study have a wide diameter (diameter distribution of the 
DWCNTs ranged from 0.5 to 2.5 nm for inner tubes and from 1.2 to 3.2 nm for outer tubes) in order to 
increase the surface area and, therefore the ability to load the nanotubes with the drug. Loading of the 
drug was attempted by incubation of DWCNTs samples (1)-(3) in chloroquine diphosphate salt aqueous 
solution for 24h at room temperature. Washing by filtration on a polypropylene membrane (0.45µm) 
was used to remove free chloroquine. In this way, chloroquine-loaded DWCNTs samples (4)-(6) were 
obtained. After recovery of the DWCNTs, chemical analysis of the proportion of chlorine in the CNTs 
was used to quantify the chloroquine content of each preparation. As it can be seen in table 2, both 
samples (5) and (6) have a similar and higher chloroquine content than sample (4). Energy-dispersive X-
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ray spectroscopy (EDX) confirmed also the presence of traces of chlorine, nitrogen, phosphorus and 
oxygen in chloroquine-loaded DWCNTs which is in agreement with the presence of chloroquine 
diphosphate on the CNTs (Supplementary Material Figures S1, S2). Additionally, high-resolution 
transmission electron microscopy (HR-TEM) was used to study the structure of chloroquine-loaded 
DWCNTs. Figure 2 shows a typical HR-TEM image of sample (5). As it can be seen, apparently poorly 
organized material mainly around individual tubes is apparent. Most of the DWCNTs are covered with 
some amorphous coating, which could correspond to oxidation debris created by post-synthesis 
treatment with HNO3, but the presence of adsorbed chloroquine or even chloroquine filling inside the 
inner tube cannot be ruled out from these images given the high loading of chloroquine on the samples 
(see table 2). In fact, chloroquine can not only be adsorbed on the DWCNTs but is likely to be also 
located within the triangular channels formed between the nanotubes in a compact bundle. These 
channels are actually open and therefore, can be filled with a potential facile release. Consequently, it 
can be concluded that most of the chloroquine is loaded on the external walls of the DWCNTs both in 
debundled and bundled nanotubes. In contrast, Figure 2 (b) shows a HR-TEM image of sample (6). 
Both bundles and individual tubes with undamaged outer wall are clearly seen. Here again, the possible 
presence of chloroquine adsorbed on the DWCNTs outer wall is proposed, especially because NaOH 
treated samples are not coated by amorphous carbon. Here again, some filling inside the DWCNT can 
not be ruled out.  
 14
 
Figure 2. HR-TEM images of chloroquine loading within: (a) oxidized DWCNT (sample (5)). The 
black arrows indicate discontinuous filling with apparently poorly organized material on/in individual 
DWCNTs; some amorphous coatings on the outer walls are visible, as well as a destroyed tip of an 
oxidized DWCNT (white arrow); (b) opened DWCNTs (sample (6)): the black arrows indicate the 
probable presence of poorly organized chloroquine diphosphate salt around the DWCNTs or even 
possibly inside. 
Chloroquine-loaded DWCNTs need to be coated with a polymer in order to be dispersed in aqueous 
media and to be able to bind DNA for the gene delivery purposes of this work. As chloroquine seems to 
be mainly adsorbed on the DWCNTs walls, an important aspect to be studied is the effect of this 
polymer coating on the retention of the chloroquine loading of the DWCNTs. This coating has an effect 
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on the displacement of chloroquine adsorbed on the external wall of the DWCNTs by the coating 
polymer. However, chloroquine that may be loaded within the triangular lattice of compact bundles 
should not be affected. Additionally, the polymer coating procedure includes further washing steps that 
can reduce the total chloroquine loading on DWCNTs. Consequently, the effect of the coating procedure 
on the retention of the chloroquine loading has to be evaluated. RNA was used as coating agent for the 
dispersion with high yield and standardization of DWCNTs samples (see Supplementary Material S3) 
[34].  
DWCNT preparations, (4)-(6) were coated with RNA (obtaining samples (10)-(12)) alongside control 
samples of DWCNTs non-loaded with chloroquine (1)-(3) (obtaining samples (7)-(9)). Gel 
electrophoresis was used to quantify the chloroquine content of the DWCNT preparations (see 
Supplementary Material Figure S4). Positively charged chloroquine migrates to the cathode and can be 
directly detected in the gel thanks to its intrinsic fluorescence, both qualitatively from its Rf (retention 
factor) and quantitative from its band intensity [35]. A known amount of RNA-coated DWCNTs can be 
loaded on the gel so that the released chloroquine can be accurately detected and quantified on the gel as 
the intensity of the chloroquine band is proportional to the concentration of the drug. No chloroquine 
band was detected for non-loaded DWCNTs samples ((7)-(9)) being only detected for chloroquine-
loaded DWCNTs samples ((10)-(12)), as expected. Release of chloroquine from loaded DWCNTs was 
clearly promoted in acidic conditions (Figure 3 lane c) compared to neutral pH (Figure 3 lane b). This 
can be accounted for tendency of the hydrophobic nanotubes to repel the protonated nitrogen of the 
quinoline ring of chloroquine at acidic pH leading to the drug’s rapid release from the tubes and a 
consequent sharp band on electrophoresis. In contrast, the samples loaded at neutral pH generated a long 
tail of chloroquine through the gel which is consistent with greater retention of the drug on the 
nanotubes and slower release throughout the electrophoresis procedure. The quantification of the 
loading of chloroquine was performed using the chloroquine band obtained at acidic pH as it 
corresponds to a complete chloroquine release from the loaded DWCNTs. This quantification is shown 
in table 2. As it can be seen, the chloroquine loading on DWCNTs decreases after the polymer coating 
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as expected. In addition, DWCNTs preparations (11) and (12) retained the loaded chloroquine on the 
nanotubes after polymer coating with higher yield. Therefore, DWCNTs (5) and (6) are the best starting 
material for obtaining optimum chloroquine loading after polymer coating. Cell viability assays were 
performed with samples (7)-(12) in order to investigate their cytotoxicity and select the best material for 
the biological applications of this work (see Supplementary Material section S4). Sample (5) was 
identified as the one that showed the lowest cytotoxicity. Therefore, sample (5), which corresponds to 
chloroquine-loaded oxidized DWCNTs, was selected as optimum for the main purpose of this work and 
will be used in the following studies. 
 
 
 
 
 
 
 
 
Figure 3. Agarose gel electrophoresis pattern of chloroquine-loaded DWCNTs. A) agarose gel: lane a: 
free chloroquine 75 µM, lane b: RNA-coated chloroquine-loaded DWCNTs 0.52 mg mL-1 dispersed in 
deionized water, lane c: RNA-coated chloroquine-loaded DWCNTs 0.52 mg mL-1 dispersed in 
hydrochloric acid 0.3 %. B) Profile of the chloroquine bands in the different lanes (a-c). Sample (11) is 
shown in this figure as a model. 
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DWCNT sample Chloroquine [wt %]a  DWCNT sample Chloroquine [wt %]b 
(7) 53.8 (10) 2.0 
(8) 59.0 (11) 10.5 
(9) 73.2 (12) 12.9 
 
Table 2. Quantification of chloroquine of DWCNTs samples by elemental analysisa (before polymer 
coating) and electrophoresisb (after polymer coating of DWCNTs).  
 
3.2. Evaluation of chloroquine-loaded DWCNTs as drug delivery system. 
Chloroquine-loaded DWCNTs were evaluated as drug delivery system. For this purpose cell viability 
assays with the chloroquine-loaded DWCNTs were carried out. For these purpose, we investigated 
cytotoxicity of the chloroquine-loaded DWCNTs using the HeLa human cell line as target and the MTT 
cell viability assay in which the MTT substrate (3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium 
bromide, a tetrazole) is reduced to purple formazan in the mitochondria of living cells. RNA-coated 
DWCNTs both chloroquine-loaded (sample (11)) and non-loaded as a control (sample (8)) were used in 
these studies. RNA gives a high dispersion yield (between 1 and 2 orders of magnitude higher than with 
the other coatings) and allowed us the testing of cytotoxicity for a wider range of DWCNTs 
concentrations. As it can be seen in Figure 4(a), non-loaded DWCNTs showed no cytotoxicity in the 
range of concentrations studied. However, chloroquine-loaded DWCNTs presented a higher cytotoxicity 
(LD50 value of 190 µg mL-1). This higher cytotoxicity of chloroquine-loaded tubes compared to non-
loaded ones was presumably due to the release of the drug, which is cytotoxic on its own (Figure 4(b)). 
Note however that free chloroquine is cytotoxic at concentrations much higher than the total 
chloroquine concentration in the DWCNTs suspensions. The total dose of chloroquine carried by the 
DWCNTs was calculated (see table 2) and depicted in Figure 4(b), showing a shift of one order of 
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magnitude towards lower concentrations compared to free drug. As it can be seen, DWCNTs are able to 
deliver the drug into the cells with higher efficiency than free drug (LD50 free chloroquine 46 µg mL-1, 
LD50 chloroquine loaded on DWCNTs 16 µg mL-1), proving the efficiency of DWCNTs as drug 
delivery system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. MTT cell viability tests with of HeLa cells treated with non-loaded oxidized DWCNTs 
(sample (8)) ((a) dotted lines) and chloroquine-loaded oxidized DWCNTs (sample (11)) ((a) black solid 
lines). All DWCNTs samples were coated with RNA prior to the assay. The effect of free chloroquine is 
shown in ((b) black line) compared to chloroquine loaded on oxidized DWCNTs ((b) grey line). 
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We next investigated the mechanism of drug release from the DWCNTs. The mechanism of entry of the 
DWCNTs in HeLa cells was studied showing internalization by an endocytic pathway (see 
Supplementary Material section S5), which is in agreement with previous studies [8]. When the 
DWCNTs are internalized by this mechanism, they are brought into the cytoplasm (pH 7.4) inside an 
endosome that finally matures into a lysosome, an acidic cellular compartment (pH 4.8). As it was 
shown in Figure 3, chloroquine release was promoted at acidic pH, the drug being retained on the 
loaded DWCNTs at neutral pH. The kinetics of the release of chloroquine from DWCNTs was therefore 
investigated at neutral and acidic pH. Chloroquine-loaded DWCNTs coated with a cationic polymer (to 
simulate the future gene delivery conditions) were used for this study (sample (13)). The chloroquine-
loaded DWCNTs were incubated at 37 oC (physiological temperature) at pH 4.8, corresponding to the 
typical pH for the lysosomal compartment, and pH 7.4, corresponding to cytoplasmic pH before 
electrophoresis. Aliquots of these incubation mixtures were taken at different times, treated as described 
in the experimental section, and run in agarose gel electrophoresis (pH 4.8 Figure 5(a); pH 7.4 Figure 
5(b)). The intensity of the chloroquine bands was quantified by pixel intensity/counting using ImageJ 
imaging software (Figure 5(c)). As it can be seen, the kinetics of chloroquine release from the DWCNTs 
was clearly accelerated at lysosomal pH (a mathematical model was developed for the kinetic 
description of chloroquine release from the DWCNTs that fitted the experimental kinetic curves 
(Supplementary Material section S6)). This fact confirms the triggered release of chloroquine from 
DWCNTs by a pH decrease. In this way, the results obtained in Figure 4(b) are confirmed by this 
mechanism. The pH-triggered drug delivery from by DWCNTs in the lysosomes produces higher levels 
of the drug inside the cell, reaching cytotoxic values at drug concentrations lower than for free drug. 
The enhanced release of the drug at acidic pH from DWCNTs is clearly an advantage for gene therapy. 
Chloroquine remains on the DWCNTs at physiological conditions and the internalization of the drug-
loaded DWCNTs inside the acidic lysosomes of the cells triggers the release of the drug into the cells. 
Therefore, chloroquine is only released from DWCNTs in the targeted cellular compartment, the 
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lysosome. The released drug being co-delivered with a gene would lead to enhanced gene transfection 
efficiencies given its lysosomotropic properties. These properties were therefore further explored in the 
following section. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Kinetics of chloroquine release from chloroquine-loaded DWCNTs vs pH. (a: pH 4.8, b: pH 
7.4) in universal buffer 0.1 M and at 37 oC (PLP-coated oxidized DWCNT concentration 1.14 mg.mL-1, 
Sample (13) was used in this study; PLP was selected as cationic polymer as it gave the best dispersion 
conditions of oxidized DWCNTs and therefore, the best accuracy and sensitivity for the chloroquine 
detection. Furthermore, the cationic polymer simulates the in vitro drug release conditions that will be 
tested. In all samples, sucrose at 6.67 % was added as loading solution and the gel was run at 90 V for 
30 min. Agarose gel electrophoresis of the permeates of the aliquots taken and filtered at 0 min, 30 min, 
60 min, 90 min, 2 h, 3h and 24 h. The quantification of the chloroquine bands of (a) and (b) is shown in 
(c) at pH 4.8 (curve a, corresponding to Figure 5 (a)) and pH 7.4 (curve b, corresponding to Figure 5 
(b)); the intensity band was normalized by the maximum intensity band value. Data were fitted using a 
mathematical model (Supplementary Material). 
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3.3. Evaluation of chloroquine-loaded DWCNTs as gene delivery system. 
We next investigated the ability of chloroquine-loaded DWCNTs to deliver a functional gene 
encoding the enzyme luciferase. To interact with cells and deliver genes the nanotubes needed to be 
funtionalized to be able to bind DNA. In this way, DWCNTs were coated with different cationic 
polymers in order to disperse them in aqueous media, to test their ability in binding negatively charged 
plasmid DNA (pGL3 plasmid encoding luciferase gene), and in evaluating these complexes (DWCNT-
cationic polymer-pGL3, both chloroquine-loaded and non-loaded) in transfecting HeLa cells. Coating of 
DWCNTs with the cationic polymers 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
[amino(polyethylene glycol)2000] (DSPEA-PEG), (Poly(Lys:Phe, 1:1) (PLP) and polyethyleneimine 
(PEI) was tested (samples (15)-(20)). Good dispersion of DWCNTs was obtained with these coatings 
being the complexes able to bind the plasmid DNA with high efficiency (see Supplementary Material 
section S3). These complexes were tested to study their efficiency in delivering pGL3 plasmid and the 
effect of their chloroquine loading on the transfection efficiency.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Luciferase expression (measured as relative luminescence units (RLU) per total µg of protein) 
from pGL3 plasmid transfected by DWCNTs without (grey bars) and with (black bars) chloroquine 
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loading. Naked pGL3 plasmid and PEI-pGL3 complexes (PEI 0.001 % (w/w) without (dotted grey bars) 
and with 75 µg mL-1 chloroquine (dotted black bars) in the transfection media are shown as controls. 75 
µg mL-1 of free chloroquine was the concentration for optimum transfection in HeLa cells; in addition 
nor luciferase expression was obtained for lower free chloroquine concentrations neither for other PEI 
concentrations (0.01 % (w/w) and lower). For transfection with DWCNTs, non-loaded oxidized 
DWCNTs coated with different cationic polymers and complexed with pGL3 plasmid (samples (15), 
(17) and (19)) in the optimum conditions (For PEI-coated DWCNTs 6 µg mL-1 of DWCNTs were used; 
for PLP-coated and DSPEA-PEG-coated DWCNTs 12 µg mL-1 of DWCNTs were used) were used as 
controls (grey bars). Transfection efficiencies of the respective chloroquine-loaded oxidized DWCNTs 
coated with the different cationic polymers and complexed with pGL3 plasmid (samples (16), (18) and 
(20)) are depicted in black bars. Transfection efficiencies of chloroquine-loaded and non-loaded raw and 
opened DWCNTs coated with PEI and complexed with pGL3 plasmid (samples (21)-(24)) are also 
depicted (DWCNTs concentration 6 µg mL-1). pGL3 plasmid concentration in the transfection mixtures 
was 20 ng µL-1. Lipofectamine was used as positive control to assess the effectiveness of the gene 
delivery vector based on DWCNTs; the system based on DWCNTs reached in the optimum conditions 
around 10 % of the transfection efficiency of lipofectamine. 
 
As it can be seen in Figure 6, choroquine-loaded DWCNTs coated with PEI showed the highest 
transfection efficiencies when compared with their controls (non-loaded DWCNTs, naked plasmid and 
free PEI, with free chloroquine and no free chloroquine addition). Furthermore, the ability of the coating 
polymer to bind plasmid DNA has an effect on the transfection efficiency. The transfection efficiencies 
for PEI-coated (sample (20)), PLP-coated (sample (18)) and DSPEA-PEG-coated DWCNTs (sample 
(16)) were in the relative efficiencies 1:0.2:0.07 at the optimum conditions, which is related to the 
relative DNA binding properties of DWCNTs coated with the different cationic polymers 
(1.0:0.16:0.037 for PEI-coated, PLP-coated and DSPEA-PEG-coated DWCNTs, respectively (see 
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Supplementary Material). There was a clear enhancement of transfection efficiency by using 
chloroquine-loaded DWCNTs, of about two orders of magnitude when compared with controls. Note 
that this result was obtained at a chloroquine concentration in the entire transfection mixture lower than 
1 µM (estimated from the DWCNT concentration in the transfection mixture and loading yield of the 
nanotubes with chloroquine) that was much lower than the concentration normally added to culture 
media as free drug for optimum transfection (of 25 - 100 µM) [36,37,38]; and so was highly unlikely to 
be due to leeching out of the chloroquine prior to entry of CNTs inside cells. The other forms of 
DWCNTs assayed for optimizing chloroquine loading were also tested to investigate the effect of 
chloroquine loading on DWCNTs on the transfection efficiency. As it can be seen, as the chloroquine 
loading increases the transfection efficiency increases (chloroquine loading are in the order (24) < (20) 
< (22) corresponding to opened < oxidized < raw DWCNTs). However, as explained in section 3.5, 
sample (20) showed the lowest cytotoxicity and therefore, it was selected as optimum. In addition, these 
DWCNT showed no cytotoxicity at the concentration levels needed for optimum gene delivery (see 
Supplementary Material section S4). In conclusion, chloroquine-loaded oxidized DWCNTs coated with 
PEI (sample (20) were selected as optimum gene delivery system. The overall approach of this 
methodology is illustrated in Figure 7. It is therefore highly likely that the enhancement of transfection 
efficiency was due to the release of chloroquine from the loaded tubes on their capture into lysosomes 
and subsequent chloroquine-mediated promotion of lysosomal escape for the DNA cargo. It seems 
likely that the released PEI-plasmid complexes are then able to cross the nuclear envelope [39] leading 
to efficient plasmid transcription and subsequent translation. 
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Figure 7. Schematic illustrating use of DWCNTs loaded with chloroquine and coated with PEI for gene 
delivery. The functionalized DWCNTs are internalized in the cell by endocytosis and delivered to the 
endosome which matures to a lysosome. Acidification causes the protonation of chloroquine and 
triggers its release from the DWCNT. The accumulation of protonated chloroquine in the lysosome 
causes swelling and the rupture of the vesicle releasing the DWCNT-PEI-plasmid complex into the 
cytoplasm. The plasmid is then able to diffuse through the cytoplasm and enter into the nucleus, where 
it is transcribed and the mRNA subsequently translated (in the cytoplasm) to yield luciferase enzyme. 
4. Summary 
These studies have demonstrated a new methodology for improved gene delivery based on the loading 
of DWCNTs with the lysosomotropic compound chloroquine capable of promoting escape of the DNA 
cargo from lysosomes. Chloroquine is an established anti-malarial drug that is administered to 
 25
thousands of patients each year, so its toxicological properties are already well characterized. Acid 
treated (oxidized) DWCNTs coated with PEI and loaded with chloroquine showed the best results for 
gene delivery. Cell viability tests showed no cytotoxicity of the functionalized DWCNTs at 
concentrations needed for optimum gene delivery. The triggered release of chloroquine from the 
DWCNTs in the lysosomes was also demonstrated, together with the use of the DWCNTs as a dual drug 
and gene delivery system. These results support the potential applications of chloroquine-loaded CNTs 
for gene therapy. 
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